Methadone as HIV prevention: High Volume Methadone Sites to decrease HIV incidence rates in resource limited settings

International Journal of Drug Policy

Volumn 21, Issue 2, 2010, Pages 122-124

  Bruce, R Douglas ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIV prevention; Injection drug use; Methadone; Opioid dependence

Indexed keywords

METHADONE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH STATUS; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INTRAVENOUS DRUG ABUSE; MENTAL HEALTH; MENTAL HEALTH CARE; MORBIDITY; MORTALITY; NONHUMAN; OPIATE ADDICTION; PRIMARY PREVENTION; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RISK FACTOR; RISK REDUCTION; THERAPY DELAY; VIRUS TRANSMISSION;

EID: 77649275644     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2009.10.004     Document Type: Note

References (31)

1. Abdala N., Carney J.M., Durante A.J., Klimov N., Ostrovski D., Somlai A.M., et al. Estimating the prevalence of syringe-borne and sexually transmitted diseases among injection drug users in St Petersburg, Russia. International Journal of STD & AIDS 14 10 (2003) 697-703
2. Anonymous. Risk behaviors for HIV transmission among intravenous-drug users not in drug treatment-United States, 1987-1989. Morbidity & Mortality Weekly Report 39 16 (1990) 273-276
3. Ball J., and Ross A. The effectiveness of methadone maintenance treatment (1991), Springer-Verlag, New York
4. Battjes R.J., Pickens R.W., and Amsel Z. HIV infection and AIDS risk behaviors among intravenous drug users entering methadone treatment in selected U.S. cities. Journal of Acquired Immune Deficiency Syndromes 4 11 (1991) 1148-1154
5. Bruce R., and Altice F. Clinical care of the HIV-infected drug user. Infectious Disease Clinics of North America 21 1 (2007) 149-179 ix
6. Buning E.C., Coutinho R.A., van Brussel G.H., van Santen G.W., and van Zadelhoff A.W. Preventing AIDS in drug addicts in Amsterdam. Lancet 1 8495 (1986) 1435
7. Caiaffa W.T., Proietti F.A., Carneiro-Proietti A.B., Mingoti S.A., Doneda D., Gandolfi D., et al. The dynamics of the human immunodeficiency virus epidemics in the south of Brazil: Increasing role of injection drug users. Clinical Infectious Diseases 37 Suppl 5 (2003) S376-381
8. Davstad I., Stenbacka M., Leifman A., and Romelsjo A. An 18-year follow-up of patients admitted to methadone treatment for the first time. Journal of Addictive Diseases 28 1 (2009) 39-52
9. Dolan K., Hall W., and Wodak A. Methadone maintenance reduces injecting in prison [see comment]. BMJ 312 7039 (1996) 1162
10. Donny E.C., Walsh S.L., Bigelow G.E., Eissenberg T., and Stitzer M.L. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans. Psychopharmacology 161 2 (2002) 202-212
11. Doran C.M., Shanahan M., Mattick R.P., Ali R., White J., and Bell J. Buprenorphine versus methadone maintenance: A cost-effectiveness analysis. Drug and Alcohol Dependence 71 3 (2003) 295-302
12. Gossop M., Marsden J., Stewart D., and Rolfe A. Patterns of improvement after methadone treatment: 1 year follow-up results from the National Treatment Outcome Research Study. Drug and Alcohol Dependence 60 3 (2000) 275-286
13. Hall W., Darke S., Ross M., and Wodak A. Patterns of drug use and risk-taking among injecting amphetamine and opioid drug users in Sydney, Australia. Addiction 88 4 (1993) 509-516
14. Himelhoch S., Chander G., Fleishman J.A., Hellinger J., Gaist P., and Gebo K.A. Access to HAART and utilization of inpatient medical hospital services among HIV-infected patients with co-occurring serious mental illness and injection drug use. General Hospital Psychiatry 29 6 (2007) 518-525
15. Kerr T., Wodak A., Elliott R., Montaner J.S., and Wood E. Opioid substitution and HIV/AIDS treatment and prevention. Lancet 364 9449 (2004) 1918-1919
16. Loimer N., Werner E., and Presslich O. Sharing spoons: A risk factor for HIV-1 infection in Vienna. British Journal of Addiction 86 6 (1991) 775-778
17. Lucas G.M., Mullen B.A., Weidle P.J., Hader S., McCaul M.E., and Moore R.D. Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups. Clinical Infectious Diseases 42 11 (2006) 1628-1635
18. Marsch L.A. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: A meta-analysis. Addiction 93 4 (1998) 515-532
19. Mathers B.M., Degenhardt L., Phillips B., Wiessing L., Hickman M., Strathdee S.A., et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. Lancet 372 9651 (2008) 1733-1745
20. McCurdy S.A., Ross M.W., Kilonzo G.P., Leshabari M.T., and Williams M.L. HIV/AIDS and injection drug use in the neighborhoods of Dar es Salaam, Tanzania. Drug and Alcohol Dependence 82 Suppl.1 (2006) S23-27
21. Metzger D.S., Woody G.E., McLellan A.T., O'Brien C.P., Druley P., Navaline H., et al. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndromes 6 9 (1993) 1049-1056
22. Murray J.B. Effectiveness of methadone maintenance for heroin addiction. Psychological Reports 83 1 (1998) 295-302
23. Newman R.G. Narcotic addiction and methadone treatment in Hong Kong: Lessons for the United States. Journal of Public Health Policy 6 4 (1985) 526-538
24. Qian H.Z., Hao C., Ruan Y., Cassell H.M., Chen K., Qin G., et al. Impact of methadone on drug use and risky sex in China. Journal of Substance Abuse Treatment 34 4 (2008) 391-397
25. Roux P., Carrieri M.P., Villes V., Dellamonica P., Poizot-Martin I., Ravaux I., et al. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: Evidence from the MANIF2000 cohort study. Addiction 103 11 (2008) 1828-1836
26. Saelim A., Geater A., Chongsuvivatwong V., Rodkla A., and Bechtel G.A. Needle sharing and high-risk sexual behaviors among IV drug users in Southern Thailand. AIDS Patient Care & STDS 12 9 (1998) 707-713
27. Schwartz R.P., Jaffe J.H., Highfield D.A., Callaman J.M., and O'Grady K.E. A randomized controlled trial of interim methadone maintenance: 10-Month follow-up. Drug and Alcohol Dependence 86 1 (2007) 30-36
28. Stenbacka M., Leifman A., and Romelsjo A. The impact of methadone treatment on registered convictions and arrests in HIV-positive and HIV-negative men and women with one or more treatment periods. Drug and Alcohol Review 22 1 (2003) 27-34
29. Tegger M.K., Crane H.M., Tapia K.A., Uldall K.K., Holte S.E., and Kitahata M.M. The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals. AIDS Patient Care & STDS 22 3 (2008) 233-243
30. Yancovitz S.R., Des Jarlais D.C., Peyser N.P., Drew E., Friedmann P., Trigg H.L., et al. A randomized trial of an interim methadone maintenance clinic. American Journal of Public Health 81 9 (1991) 1185-1191
31. Zhang C., Yang R., Xia X., Qin S., Dai J., Zhang Z., et al. High prevalence of HIV-1 and hepatitis C virus coinfection among injection drug users in the southeastern region of Yunnan, China. Journal of Acquired Immune Deficiency Syndromes 29 2 (2002) 191-196